mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.099 |
0.05 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.07 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.095 |
0.07 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |